SCHEMBL5617848

SCHEMBL5617848

CCn1c(C(C#N)c2nc(NCCc3cccnc3)ncc2C)nc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.49
MAPK9 P45984 1/20 0.49
MAPK10 P53779 1/20 0.49
MKNK2 Q9HBH9 11/20 0.47
MKNK1 Q9BUB5 10/20 0.47
ALOX5AP P20292 1/20 0.40
OGA O60502 1/20 0.39
INSR P06213 1/20 0.38
IGF1R P08069 1/20 0.38
FGFR1 P11362 1/20 0.38
KDR P35968 1/20 0.38
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
KMT2A Q03164 1/20 0.36
CTSL P07711 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
RUNX1 Q01196 1/20 0.35
CBFB Q13951 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5618494 0.87 MAPK10 (0.62) MAPK8MAPK9MAPK10MKNK2MKNK1
SCHEMBL5617651 0.86 ALDH1A1 (0.45) MKNK2MKNK1ALOX5APOGAFGFR1
SCHEMBL5618342 0.86 HTT (0.37) MAPK8MAPK9MAPK10MKNK2MKNK1
SCHEMBL5398186 0.84 MAPK8 (0.48) MAPK8MAPK9MAPK10MKNK2MKNK1
SCHEMBL5427414 0.82 NPSR1 (0.36) MKNK2MKNK1ALOX5APMEN1PKM
SCHEMBL5618220 0.81 MAPK8 (0.44) MAPK8MAPK9MAPK10MKNK2MKNK1
SCHEMBL3562691 0.80 MAPK10 (0.52) MAPK8MAPK9MAPK10MKNK2MKNK1
SCHEMBL5617940 0.79 MAPK10 (0.50) MAPK8MAPK9MAPK10MKNK2MKNK1
SCHEMBL5617823 0.79 SMN1; SMN2 (0.48) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL5618112 0.78 NPSR1 (0.39) MAPK8MAPK9MAPK10MKNK2MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070203134-A1 Benzimidazole Acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203134-A1 Benzimidazole Acetonitriles PKD1, GPR119, CCNI MAPK8 2377/4885MAPK9 3702/4885MAPK10 4253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.